Andlauer Healthcare Group Future Growth
Future criteria checks 0/6
Andlauer Healthcare Group is forecast to grow revenue at 4.8% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare earnings growth | 62.6% |
| Revenue growth rate | 4.8% |
| Future return on equity | 16.3% |
| Analyst coverage | Good |
| Last updated | 13 Feb 2025 |
Recent future growth updates
Recent updates
We Think Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt With Ease
Nov 07
Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return
Oct 17Andlauer Healthcare Group (TSE:AND) Is Increasing Its Dividend To CA$0.11
Sep 20Here's Why Andlauer Healthcare Group (TSE:AND) Can Manage Its Debt Responsibly
May 23These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Reasonably Well
Jan 30Return Trends At Andlauer Healthcare Group (TSE:AND) Aren't Appealing
Aug 24Market Participants Recognise Andlauer Healthcare Group Inc.'s (TSE:AND) Earnings
May 05Is Andlauer Healthcare Group (TSE:AND) Using Too Much Debt?
Apr 07A Look At The Fair Value Of Andlauer Healthcare Group Inc. (TSE:AND)
Dec 22Andlauer Healthcare Group (TSE:AND) Hasn't Managed To Accelerate Its Returns
Dec 09We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease
Oct 28These 4 Measures Indicate That Andlauer Healthcare Group (TSE:AND) Is Using Debt Safely
Oct 12Here's What To Make Of Andlauer Healthcare Group's (TSE:AND) Decelerating Rates Of Return
Aug 17We Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease
Jul 19Andlauer Healthcare Group (TSE:AND) Could Easily Take On More Debt
Jul 05The Returns At Andlauer Healthcare Group (TSE:AND) Aren't Growing
May 04I Ran A Stock Scan For Earnings Growth And Andlauer Healthcare Group (TSE:AND) Passed With Ease
Apr 19Is Andlauer Healthcare Group (TSE:AND) A Risky Investment?
Feb 23Is There An Opportunity With Andlauer Healthcare Group Inc.'s (TSE:AND) 33% Undervaluation?
Jan 19We Think Andlauer Healthcare Group (TSE:AND) Might Have The DNA Of A Multi-Bagger
Jan 06Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | 753 | N/A | 138 | 156 | 1 |
| 12/31/2026 | 725 | N/A | 111 | 154 | 5 |
| 12/31/2025 | 689 | N/A | 100 | 140 | 6 |
| 12/31/2024 | 653 | N/A | 99 | 135 | 6 |
| 9/30/2024 | 651 | 66 | 103 | 127 | N/A |
| 6/30/2024 | 648 | 65 | 101 | 125 | N/A |
| 3/31/2024 | 644 | 65 | 85 | 113 | N/A |
| 12/31/2023 | 648 | 66 | 79 | 104 | N/A |
| 9/30/2023 | 645 | 67 | 87 | 116 | N/A |
| 6/30/2023 | 653 | 71 | 94 | 125 | N/A |
| 3/31/2023 | 665 | 76 | 102 | 132 | N/A |
| 12/31/2022 | 648 | 76 | 109 | 137 | N/A |
| 9/30/2022 | 616 | 110 | 109 | 129 | N/A |
| 6/30/2022 | 555 | 103 | 98 | 111 | N/A |
| 3/31/2022 | 493 | 95 | 85 | 97 | N/A |
| 12/31/2021 | 440 | 90 | 74 | 84 | N/A |
| 9/30/2021 | 394 | 51 | 54 | 61 | N/A |
| 6/30/2021 | 365 | 47 | 52 | 59 | N/A |
| 3/31/2021 | 328 | 41 | 51 | 58 | N/A |
| 12/31/2020 | 314 | 38 | 46 | 51 | N/A |
| 9/30/2020 | 304 | 31 | 64 | 72 | N/A |
| 6/30/2020 | 299 | 30 | 57 | 65 | N/A |
| 3/31/2020 | 300 | 31 | 54 | 61 | N/A |
| 12/31/2019 | 290 | 30 | 55 | 61 | N/A |
| 9/30/2019 | 285 | 28 | 44 | 49 | N/A |
| 12/31/2018 | 277 | 27 | 50 | 52 | N/A |
| 12/31/2017 | 251 | 22 | N/A | 43 | N/A |
| 12/31/2016 | 224 | 19 | N/A | 30 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if AND's forecast earnings growth is above the savings rate (2.4%).
Earnings vs Market: Insufficient data to determine if AND's earnings are forecast to grow faster than the Canadian market
High Growth Earnings: Insufficient data to determine if AND's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AND's revenue (4.8% per year) is forecast to grow slower than the Canadian market (5.3% per year).
High Growth Revenue: AND's revenue (4.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AND's Return on Equity is forecast to be low in 3 years time (16.3%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/16 10:09 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Andlauer Healthcare Group Inc. is covered by 9 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kevin Chiang | CIBC Capital Markets |
| Cameron Doerksen | National Bank Financial |
| Endri Leno | National Bank Financial |